Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
PHOSPHOTEC is an injectable diagnostic or radiopharmaceutical product approved by Bracco in 1976, with unknown mechanism of action and therapeutic indication. The exact clinical use cannot be determined from available data, but the injection route suggests imaging or diagnostic application.
Approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting a contracting commercial organization and reduced team headcount.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
PHOSPHOTEC has zero linked job openings, reflecting its mature LOE-approaching status and limited commercial momentum. Career growth on this product is constrained; professionals should expect maintenance-focused roles with limited expansion opportunities.
Worked on PHOSPHOTEC at Bracco? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.